SWOT Analysis for Icecure Medical Ltd

Significant (over 30%) distance from 52 week high
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Month
Companies with Low Debt
Stock gained more than 20% in one month
Increasing profits every quarter for the past 2 quarters
Stock with Low PE (PE < = 10)
Highest Recovery from 52 Week Low

MACD Crossover Below Signal Line
Stocks with Quarter Change % less than Industry
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
MACD crossed below signal line previous end of day
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Book Value Per Share deteriorating for last 2 years
Recent Results: Declining Operating Profit Margin and Net Profits (YoY)
Declining Revenue every quarter for the past 2 quarters
Stocks Underperforming their Industry Price Change in the Quarter